The evolution of drostanolone enanthate reflects the broader history of anabolic steroids, transitioning from medical treatment to sports use. Drostanolone itself was synthesized in the late 1950s, and the enanthate ester was later added to extend its release time. Initially intended for therapeutic use in cancer and muscle loss, the compound's unique traits—non-aromatizing action, strong androgenic properties—led to its popularity in bodybuilding. Athletes valued it for promoting muscle definition, preserving strength, and minimizing fat and fluid retention in cutting cycles.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Drostanolone Enanthate 200 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.